15-Deoxy-d-12,14-PGJ2 (BioDeep_00000002521)
Main id: BioDeep_00000629496
human metabolite Endogenous blood metabolite
代谢物信息卡片
化学式: C20H28O3 (316.2038)
中文名称: (15-脱氧-Δ12,14-前列腺素 J2
谱图信息:
最多检出来源 Homo sapiens(otcml) 40.83%
分子结构信息
SMILES: CCCCC/C=C/C=C/1\[C@@H](C/C=C\CCCC(=O)O)C=CC1=O
InChI: InChI=1S/C20H28O3/c1-2-3-4-5-6-10-13-18-17(15-16-19(18)21)12-9-7-8-11-14-20(22)23/h6-7,9-10,13,15-17H,2-5,8,11-12,14H2,1H3,(H,22,23)/b9-7-,10-6+,18-13+/t17-/m0/s1
描述信息
15-deoxy-PGJ2 (15d-PGJ2) is a metabolite of the PGJ2 prostanoid family that influences multiple signaling pathways by covalently binding with key signaling molecules. Among them, 15d-PGJ2 has displayed highest potency as an inducer of gene expression. Prostanoids are a subclass of the lipid mediator group known as eicosanoids. They derive from C-20 polyunsaturated fatty acids, mainly dihomo-gamma-linoleic (20:3n-6), arachidonic (20:4n-6), and eicosapentaenoic (20:5n-3) acids, through the action of cyclooxygenases-1 and -2 (COX-1 and COX-2). The reaction product of COX is the unstable endoperoxide prostaglandin H (PGH) that is further transformed into the individual prostanoids by a series of specific prostanoid synthases. Prostanoids are local-acting mediators formed and inactivated within the same or neighbouring cells prior to their release into circulation as inactive metabolites (15-keto- and 13,14-dihydroketo metabolites). Non-enzymatic peroxidation of arachidonic acid and other fatty acids in vivo can result in prostaglandin-like substances isomeric to the COX-derived prostaglandins that are termed isoprostanes. Prostanoids take part in many physiological and pathophysiological processes in practically every organ, tissue and cell, including the vascular, renal, gastrointestinal and reproductive systems. Their activities are mediated through prostanoid-specific receptors and intracellular signalling pathways, whilst their biosynthesis and action are blocked by nonsteroidal antiinflammatory drugs (NSAID). Isoprostanes are considered to be reliable markers of oxidant stress status and have been linked to inflammation, ischaemia-reperfusion, diabetes, cardiovascular disease, reproductive disorders and diabetes. (PMID: 16986207, 16857669). Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways.
D007155 - Immunologic Factors
同义名列表
32 个代谢物同义名
(5Z)-7-[(1S,5E)-5-[(2E)-oct-2-en-1-ylidene]-4-oxocyclopent-2-en-1-yl]hept-5-enoic acid; (5Z,12E,14E)-11-oxo-Prosta-5,9,12,14-tetraen-1-Oic acid; (5Z,12E,14E) 11-oxo Prosta-5,9,12,14-tetraen-1-Oic acid; (5Z,12E,14E) 11-oxo Prosta-5,9,12,14-tetraen-1-Oate; (5Z,12E,14E)-11-oxo-Prosta-5,9,12,14-tetraen-1-Oate; 11-oxo-5Z,9,12E,14E-prostatetraenoic acid; 11-oxo-5Z,9,12,14-Prostatetraenoic acid; 15-Deoxy-delta(12,14)-prostaglandin J2; 15-Deoxy-delta 12, 14-prostaglandin J2; 15-deoxy-delta-12,14-Prostaglandin J2; 15-Deoxy-Delta12,14-prostaglandin J2; 11-oxo-5Z,9,12,14-Prostatetraenoate; 15-Deoxy-δ-12,14-prostaglandin J2; 15-Deoxy-delta12,14-prostaglandin; 15d-PGJ2;15-Deoxy-Delta12,14-PGJ2; 15-Deoxy-δ12,14-prostaglandin J2; 15-Deoxy-12,14-prostaglandin J2; 15-Deoxy-delta-12, 14 PGJ-2; 15-deoxy-δ-12,14-PGJ2; 15-deoxy-delta-12,14-PGJ2; 15-Deoxy-prostaglandin J2; 15-Deoxy-delta(12,14)PGJ2; delta-12,14-15-Deoxy-PGJ2; 15-Deoxy-delta12,14-PGJ2; 15-Deoxyprostaglandin J2; 15-Deoxy-δ-12,14-PGJ2; 15-Deoxy-d-12,14-PGJ2; Δ-12,14-15-deoxy-PGJ2; 15-Deoxy-Delta12; Delta12,14-PGJ2; 15-deoxy-PGJ2; 15D-PGJ2
数据库引用编号
16 个数据库交叉引用编号
- ChEBI: CHEBI:34159
- KEGG: C14717
- PubChem: 5311211
- PubChem: 1444
- HMDB: HMDB0005079
- Metlin: METLIN36099
- ChEMBL: CHEMBL482477
- foodb: FDB112223
- chemspider: 4470730
- CAS: 87893-55-8
- CAS: 87-57-0
- PMhub: MS000003204
- PubChem: 17395716
- LipidMAPS: LMFA03010021
- NIKKAJI: J2.788.586A
- RefMet: 15-Deoxy-delta-12,14-PGJ2
分类词条
相关代谢途径
Reactome(5)
BioCyc(0)
PlantCyc(0)
代谢反应
56 个相关的代谢反应过程信息。
Reactome(5)
- Metabolism:
3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-one-CoA + CoA-SH ⟶ choloyl-CoA + propionyl CoA
- Metabolism of lipids:
1-3-oxo-THA-CoA + CoA-SH ⟶ DHA-CoA + propionyl CoA
- Fatty acid metabolism:
ATP + PROP-CoA + carbon dioxide ⟶ ADP + MEMA-CoA + Pi
- Arachidonic acid metabolism:
H+ + e- + prostaglandin G2 ⟶ H2O + prostaglandin H2
- Synthesis of Prostaglandins (PG) and Thromboxanes (TX):
H+ + e- + prostaglandin G2 ⟶ H2O + prostaglandin H2
BioCyc(0)
WikiPathways(5)
- Eicosanoid lipid synthesis map:
PGH2 ⟶ PGE2
- Eicosanoid metabolism via cyclooxygenases (COX):
Arachidonic acid ⟶ 15(S)-HETE
- Eicosanoid synthesis:
PGD2 ⟶ PGJ2
- Arachidonic acid (AA, ARA) oxylipin metabolism:
HXB3 ⟶ Trioxilin B3
- Eicosanoid metabolism via cyclooxygenases (COX):
Arachidonic acid ⟶ 15(S)-HETE
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(46)
- Piroxicam Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Acetylsalicylic Acid Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Etodolac Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Ketoprofen Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Ibuprofen Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Rofecoxib Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Diclofenac Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Sulindac Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Celecoxib Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Ketorolac Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Suprofen Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Bromfenac Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Indomethacin Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Mefenamic Acid Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Oxaprozin Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Nabumetone Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Naproxen Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Diflunisal Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Meloxicam Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Valdecoxib Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Antipyrine Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Antrafenine Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Carprofen Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Etoricoxib Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Fenoprofen Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Flurbiprofen Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Magnesium Salicylate Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Lumiracoxib Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Lornoxicam Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Phenylbutazone Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Nepafenac Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Arachidonic Acid Metabolism:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Tolmetin Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Tiaprofenic Acid Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Tenoxicam Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Salsalate Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Salicylate-Sodium Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Salicylic Acid Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Trisalicylate-Choline Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Arachidonic Acid Metabolism:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Leukotriene C4 Synthesis Deficiency:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Leukotriene C4 Synthesis Deficiency:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Arachidonic Acid Metabolism:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Arachidonic Acid Metabolism:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Leukotriene C4 Synthesis Deficiency:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
- Acetaminophen Action Pathway:
Glutathione + Leukotriene A4 ⟶ Leukotriene C4
PharmGKB(0)
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:
- PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。
文献列表
- Stephanie Kim, Eric Reed, Stefano Monti, Jennifer J Schlezinger. A Data-Driven Transcriptional Taxonomy of Adipogenic Chemicals to Identify White and Brite Adipogens.
Environmental health perspectives.
2021 07; 129(7):77006. doi:
10.1289/ehp6886
. [PMID: 34323617] - Wonki Kim, Jeong-Hoon Jang, Xiancai Zhong, Hyungseok Seo, Young-Joon Surh. 15-Deoxy-△12,14-Prostaglandin J2 Promotes Resolution of Experimentally Induced Colitis.
Frontiers in immunology.
2021; 12(?):615803. doi:
10.3389/fimmu.2021.615803
. [PMID: 33633749] - A Sikora-Wiorkowska, A Smolen, G Czechowska, K Wiorkowski, A Korolczuk. The role of PPAR gamma agonists - rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2 in experimental cyclosporine A hepatotoxicity.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
2019 Dec; 70(6):. doi:
10.26402/jpp.2019.6.07
. [PMID: 32084649] - Ivelina Urban, Martin Turinsky, Sviatlana Gehrmann, Jakob Morgenstern, Maik Brune, Moritz R Milewski, Andreas H Wagner, Cordula Rumig, Thomas Fleming, Florian Leuschner, Christian A Gleissner, Markus Hecker. 15-Deoxy-Δ12,14-Prostaglandin J2 Reinforces the Anti-Inflammatory Capacity of Endothelial Cells With a Genetically Determined NO Deficit.
Circulation research.
2019 07; 125(3):282-294. doi:
10.1161/circresaha.118.313820
. [PMID: 31213138] - Dorottya Nagy-Szakal, Dinesh K Barupal, Bohyun Lee, Xiaoyu Che, Brent L Williams, Ellie J R Kahn, Joy E Ukaigwe, Lucinda Bateman, Nancy G Klimas, Anthony L Komaroff, Susan Levine, Jose G Montoya, Daniel L Peterson, Bruce Levin, Mady Hornig, Oliver Fiehn, W Ian Lipkin. Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics.
Scientific reports.
2018 07; 8(1):10056. doi:
10.1038/s41598-018-28477-9
. [PMID: 29968805] - Tatsurou Yagami, Yasuhiro Yamamoto, Hiromi Koma. Physiological and Pathological Roles of 15-Deoxy-Δ12,14-Prostaglandin J2 in the Central Nervous System and Neurological Diseases.
Molecular neurobiology.
2018 03; 55(3):2227-2248. doi:
10.1007/s12035-017-0435-4
. [PMID: 28299574] - Kan Chen, Jing-Jing Li, Sai-Nan Li, Jiao Feng, Tong Liu, Fan Wang, Wei-Qi Dai, Yu-Jing Xia, Jie Lu, Ying-Qun Zhou, Chuan-Yong Guo. 15-Deoxy-Δ12,14-prostaglandin J2 alleviates hepatic ischemia-reperfusion injury in mice via inducing antioxidant response and inhibiting apoptosis and autophagy.
Acta pharmacologica Sinica.
2017 May; 38(5):672-687. doi:
10.1038/aps.2016.108
. [PMID: 28216619] - Hiromi Koma, Yasuhiro Yamamoto, Ayaka Nishii, Tatsurou Yagami. 15-Deoxy-Δ12,14-prostaglandin J2 induced neurotoxicity via suppressing phosphoinositide 3-kinase.
Neuropharmacology.
2017 02; 113(Pt A):416-425. doi:
10.1016/j.neuropharm.2016.10.017
. [PMID: 27771378] - Elda Grabocka, Dafna Bar-Sagi. Mutant KRAS Enhances Tumor Cell Fitness by Upregulating Stress Granules.
Cell.
2016 Dec; 167(7):1803-1813.e12. doi:
10.1016/j.cell.2016.11.035
. [PMID: 27984728] - Takahiro Shibata. 15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂ as an electrophilic mediator.
Bioscience, biotechnology, and biochemistry.
2015; 79(7):1044-9. doi:
10.1080/09168451.2015.1012149
. [PMID: 26011133] - S B Wall, J-Y Oh, L Mitchell, A H Laube, S L Campbell, M B Renfrow, A Landar. Rac1 modification by an electrophilic 15-deoxy Δ(12,14)-prostaglandin J2 analog.
Redox biology.
2015; 4(?):346-54. doi:
10.1016/j.redox.2015.01.016
. [PMID: 25677088] - A Korolczuk, M Maciejewski, A Smolen, J Dudka, G Czechowska, I Widelska. The role of peroxisome-proliferator-activating receptor gamma agonists: rosiglitazone and 15-deoxy-delta12,14-prostaglandin J2 in chronic experimental cyclosporine A-induced nephrotoxicity.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
2014 Dec; 65(6):867-76. doi:
. [PMID: 25554991]
- Ville Paakinaho, Sanna Kaikkonen, Anna-Liisa Levonen, Jorma J Palvimo. Electrophilic lipid mediator 15-deoxy-Δ12,14-prostaglandin j2 modifies glucocorticoid signaling via receptor SUMOylation.
Molecular and cellular biology.
2014 Sep; 34(17):3202-13. doi:
10.1128/mcb.00748-14
. [PMID: 24980431] - Cecilia I Casali, Karen Weber, Daniela Faggionato, Emanuel Morel Gómez, María C Fernández Tome. Coordinate regulation between the nuclear receptor peroxisome proliferator-activated receptor-γ and cyclooxygenase-2 in renal epithelial cells.
Biochemical pharmacology.
2014 Aug; 90(4):432-9. doi:
10.1016/j.bcp.2014.06.002
. [PMID: 24915420] - Yukiko Sakaba, Hisataka Awata, Toshiaki Morisugi, Tetsuji Kawakami, Akikazu Sakudo, Yasuharu Tanaka. 15-Deoxy-Δ12,14-prostaglandin J2 induces PPARγ- and p53-independent apoptosis in rabbit synovial cells.
Prostaglandins & other lipid mediators.
2014 Jun; 109-111(?):1-13. doi:
10.1016/j.prostaglandins.2014.02.001
. [PMID: 24680891] - Elke H Heiss, Thi Van Anh Tran, Kristin Zimmermann, Stefan Schwaiger, Corina Vouk, Barbara Mayerhofer, Clemens Malainer, Atanas G Atanasov, Hermann Stuppner, Verena M Dirsch. Identification of chromomoric acid C-I as an Nrf2 activator in Chromolaena odorata.
Journal of natural products.
2014 Mar; 77(3):503-8. doi:
10.1021/np400778m
. [PMID: 24476568] - M Kurtz, E Capobianco, V Careaga, N Martinez, M B Mazzucco, M Maier, A Jawerbaum. Peroxisome proliferator-activated receptor ligands regulate lipid content, metabolism, and composition in fetal lungs of diabetic rats.
The Journal of endocrinology.
2014 Mar; 220(3):345-59. doi:
10.1530/joe-13-0362
. [PMID: 24389592] - Robert Ramer, Udo Walther, Philipp Borchert, Stefan Laufer, Michael Linnebacher, Burkhard Hinz. Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib.
Journal of lipid research.
2013 Nov; 54(11):3116-29. doi:
10.1194/jlr.m042283
. [PMID: 23943857] - Simone Marcone, Desmond J Fitzgerald. Proteomic identification of the candidate target proteins of 15-deoxy-delta12,14-prostaglandin J2.
Proteomics.
2013 Jul; 13(14):2135-9. doi:
10.1002/pmic.201200289
. [PMID: 23606334] - Ying Lu, Qiao Zhou, Fang Zhong, Shanmai Guo, Xu Hao, Cong Li, Weiming Wang, Nan Chen. 15-Deoxy-Δ(12,14)-prostaglandin J(2) modulates lipopolysaccharide-induced chemokine expression by blocking nuclear factor-κB activation via peroxisome proliferator activated receptor-γ-independent mechanism in renal tubular epithelial cells.
Nephron. Experimental nephrology.
2013; 123(1-2):1-10. doi:
10.1159/000353232
. [PMID: 23887394] - Jennifer Lefils-Lacourtablaise, Mairobys Socorro, Alain Géloën, Patricia Daira, Cyrille Debard, Emmanuelle Loizon, Michel Guichardant, Zury Dominguez, Hubert Vidal, Michel Lagarde, Nathalie Bernoud-Hubac. The eicosapentaenoic acid metabolite 15-deoxy-δ(12,14)-prostaglandin J3 increases adiponectin secretion by adipocytes partly via a PPARγ-dependent mechanism.
PloS one.
2013; 8(5):e63997. doi:
10.1371/journal.pone.0063997
. [PMID: 23734181] - Michelle M C Buckner, L Caetano M Antunes, Navkiran Gill, Shannon L Russell, Stephanie R Shames, B Brett Finlay. 15-Deoxy-Δ12,14-prostaglandin J2 inhibits macrophage colonization by Salmonella enterica serovar Typhimurium.
PloS one.
2013; 8(7):e69759. doi:
10.1371/journal.pone.0069759
. [PMID: 23922794] - Kagami Iida, Takayuki Yonezawa, Sun-Sil Choi, Kazuo Nagai, Je-Tae Woo. Sodium dodecyl sulfate and sodium dodecyl benzenesulfonate are ligands for peroxisome proliferator-activated receptor γ.
The Journal of toxicological sciences.
2013; 38(5):697-702. doi:
10.2131/jts.38.697
. [PMID: 24025786] - Efrat Sharvit, Shirley Abramovitch, Shimon Reif, Rafael Bruck. Amplified inhibition of stellate cell activation pathways by PPAR-γ, RAR and RXR agonists.
PloS one.
2013; 8(10):e76541. doi:
10.1371/journal.pone.0076541
. [PMID: 24098526] - María Eugenia Matzkin, Eliana Herminia Pellizzari, Soledad Paola Rossi, Ricardo Saúl Calandra, Selva Beatriz Cigorraga, Mónica Beatriz Frungieri. Exploring the cyclooxygenase 2 (COX2)/15d-Δ(12,14)PGJ(2) system in hamster Sertoli cells: regulation by FSH/testosterone and relevance to glucose uptake.
General and comparative endocrinology.
2012 Nov; 179(2):254-64. doi:
10.1016/j.ygcen.2012.08.020
. [PMID: 22974512] - Kyunghwa Baek, Je-Yoel Cho, Hyo Rin Hwang, Arang Kwon, Hye-Lim Lee, Hyun-Jung Park, Abdul S Qadir, Hyun-Mo Ryoo, Kyung Mi Woo, Jeong-Hwa Baek. Myeloid Elf-1-like factor stimulates adipogenic differentiation through the induction of peroxisome proliferator-activated receptor γ expression in bone marrow.
Journal of cellular physiology.
2012 Nov; 227(11):3603-12. doi:
10.1002/jcp.24064
. [PMID: 22307523] - Yajun Duan, Yuanli Chen, Wenquan Hu, Xiaoju Li, Xiaoxiao Yang, Xin Zhou, Zhinan Yin, Deling Kong, Zhi Yao, David P Hajjar, Lin Liu, Qiang Liu, Jihong Han. Peroxisome Proliferator-activated receptor γ activation by ligands and dephosphorylation induces proprotein convertase subtilisin kexin type 9 and low density lipoprotein receptor expression.
The Journal of biological chemistry.
2012 Jul; 287(28):23667-77. doi:
10.1074/jbc.m112.350181
. [PMID: 22593575] - Megumi Fujita, Chiaki Tohji, Yoko Honda, Yasuhiro Yamamoto, Tsutomu Nakamura, Tatsurou Yagami, Motohiro Yamamori, Noboru Okamura. Cytotoxicity of 15-deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma.
International journal of medical sciences.
2012; 9(7):555-66. doi:
10.7150/ijms.4455
. [PMID: 22991494] - Abu Asad Chowdhury, Mohammad Sharifur Rahman, Kohji Nishimura, Mitsuo Jisaka, Tsutomu Nagaya, Takahiro Ishikawa, Fumiaki Shono, Kazushige Yokota. 15-Deoxy-Δ(12,14)-prostaglandin J(2) interferes inducible synthesis of prostaglandins E(2) and F(2α) that suppress subsequent adipogenesis program in cultured preadipocytes.
Prostaglandins & other lipid mediators.
2011 Aug; 95(1-4):53-62. doi:
10.1016/j.prostaglandins.2011.06.002
. [PMID: 21699992] - Yasuhiro Yamamoto, Megumi Fujita, Hiromi Koma, Motohiro Yamamori, Tsutomu Nakamura, Noboru Okamura, Tatsurou Yagami. 15-Deoxy-Δ12,14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways.
Biochemical and biophysical research communications.
2011 Jul; 410(3):563-7. doi:
10.1016/j.bbrc.2011.06.026
. [PMID: 21683069] - Yasuhiro Yamamoto, Kenkichi Takase, Junji Kishino, Megumi Fujita, Noboru Okamura, Toshiyuki Sakaeda, Masafumi Fujimoto, Tatsurou Yagami. Proteomic identification of protein targets for 15-deoxy-Δ(12,14)-prostaglandin J2 in neuronal plasma membrane.
PloS one.
2011 Mar; 6(3):e17552. doi:
10.1371/journal.pone.0017552
. [PMID: 21445266] - Na Li, Rebecca C Salter, Dipak P Ramji. Molecular mechanisms underlying the inhibition of IFN-γ-induced, STAT1-mediated gene transcription in human macrophages by simvastatin and agonists of PPARs and LXRs.
Journal of cellular biochemistry.
2011 Feb; 112(2):675-83. doi:
10.1002/jcb.22976
. [PMID: 21268089] - Fu-Tian Tang, Yuan Cao, Tie-Qiao Wang, Li-Jing Wang, Jiao Guo, Xiao-Shi Zhou, Suo-Wen Xu, Wei-Hua Liu, Pei-Qing Liu, He-Qing Huang. Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression.
European journal of pharmacology.
2011 Jan; 650(1):275-84. doi:
10.1016/j.ejphar.2010.07.038
. [PMID: 20854809] - Klarissa D Hardy, Brian E Cox, Ginger L Milne, Huiyong Yin, L Jackson Roberts. Nonenzymatic free radical-catalyzed generation of 15-deoxy-Δ(12,14)-prostaglandin J₂-like compounds (deoxy-J₂-isoprostanes) in vivo.
Journal of lipid research.
2011 Jan; 52(1):113-24. doi:
10.1194/jlr.m010264
. [PMID: 20944061] - Mansoor Ali Syed, M Joo, Zulfiqar Abbas, D Rodger, J W Christman, D Mehta, R T Sadikot. Expression of TREM-1 is inhibited by PGD2 and PGJ2 in macrophages.
Experimental cell research.
2010 Nov; 316(19):3140-9. doi:
10.1016/j.yexcr.2010.08.009
. [PMID: 20797396] - S-H Kim, G-S Choi, Y-M Ye, I Jou, H-S Park, S M Park. Toluene diisocyanate (TDI) regulates haem oxygenase-1/ferritin expression: implications for toluene diisocyanate-induced asthma.
Clinical and experimental immunology.
2010 Jun; 160(3):489-97. doi:
10.1111/j.1365-2249.2010.04118.x
. [PMID: 20345975] - Sandrine Théoleyre, Stéphanie Mottier, Damien Masson, Marc G Denis. HtrA3 is regulated by 15-deoxy-Delta12,14-prostaglandin J2 independently of PPARgamma in clear cell renal cell carcinomas.
Biochemical and biophysical research communications.
2010 Apr; 394(3):453-8. doi:
10.1016/j.bbrc.2009.11.163
. [PMID: 19951697] - Hai-Xin Zhang, Kunikazu Tanji, Hidemi Yoshida, Makoto Hayakari, Takahiro Shibata, Fumiaki Mori, Koji Uchida, Koichi Wakabayashi. Alteration of biochemical and pathological properties of TDP-43 protein by a lipid mediator, 15-deoxy-Delta(12,14)-prostaglandin J(2).
Experimental neurology.
2010 Apr; 222(2):296-303. doi:
10.1016/j.expneurol.2010.01.007
. [PMID: 20083106] - Farhat L Khanim, Rachel E Hayden, Jane Birtwistle, Alessia Lodi, Stefano Tiziani, Nicholas J Davies, Jon P Ride, Mark R Viant, Ulrich L Gunther, Joanne C Mountford, Heinrich Schrewe, Richard M Green, Jim A Murray, Mark T Drayson, Chris M Bunce. Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia.
PloS one.
2009 Dec; 4(12):e8147. doi:
10.1371/journal.pone.0008147
. [PMID: 19997560] - Jai Prakash, Ruchi Bansal, Eduard Post, Alie de Jager-Krikken, Marjolijn N Lub-de Hooge, Klaas Poelstra. Albumin-binding and tumor vasculature determine the antitumor effect of 15-deoxy-Delta-(12,14)-prostaglandin-J(2) in vivo.
Neoplasia (New York, N.Y.).
2009 Dec; 11(12):1348-58. doi:
10.1593/neo.91188
. [PMID: 20019843] - Ann V Hertzel, Kristina Hellberg, Joseph M Reynolds, Andrew C Kruse, Brittany E Juhlmann, Anne J Smith, Mark A Sanders, Douglas H Ohlendorf, Jill Suttles, David A Bernlohr. Identification and characterization of a small molecule inhibitor of Fatty Acid binding proteins.
Journal of medicinal chemistry.
2009 Oct; 52(19):6024-31. doi:
10.1021/jm900720m
. [PMID: 19754198] - Katsuhiro Iinuma, Takashi Sato, Noriko Akimoto, Norihisa Noguchi, Masanori Sasatsu, Setsuko Nishijima, Ichiro Kurokawa, Akira Ito. Involvement of Propionibacterium acnes in the augmentation of lipogenesis in hamster sebaceous glands in vivo and in vitro.
The Journal of investigative dermatology.
2009 Sep; 129(9):2113-9. doi:
10.1038/jid.2009.46
. [PMID: 19282842] - Ashlee N Higdon, Brian P Dranka, Bradford G Hill, Joo-Yeun Oh, Michelle S Johnson, Aimee Landar, Victor M Darley-Usmar. Methods for imaging and detecting modification of proteins by reactive lipid species.
Free radical biology & medicine.
2009 Aug; 47(3):201-12. doi:
10.1016/j.freeradbiomed.2009.05.009
. [PMID: 19446632] - Gemma Olmos, María I Arenas, Raquel Bienes, María Jose Calzada, Julián Aragonés, Maria Laura Garcia-Bermejo, Manuel O Landazuri, Javier Lucio-Cazaña. 15-Deoxy-Delta(12,14)-prostaglandin-J(2) reveals a new pVHL-independent, lysosomal-dependent mechanism of HIF-1alpha degradation.
Cellular and molecular life sciences : CMLS.
2009 Jul; 66(13):2167-80. doi:
10.1007/s00018-009-0039-x
. [PMID: 19458911] - Olav A Gressner, Chunfang Gao, Katharina Rehbein, Birgit Lahme, Monika Siluschek, Thomas Berg, Tobias Müller, Axel M Gressner. Elevated concentrations of 15-deoxy-Delta12,14-prostaglandin J2 in chronic liver disease propose therapeutic trials with peroxisome proliferator activated receptor gamma-inducing drugs.
Liver international : official journal of the International Association for the Study of the Liver.
2009 May; 29(5):730-5. doi:
10.1111/j.1478-3231.2008.01895.x
. [PMID: 19018984] - Dong Ryeol Lee, Chae Hwa Kwon, Ji Yeon Park, Yong Keun Kim, Jae Suk Woo. 15-Deoxy-Delta(12,14)-prostaglandin J(2) induces mitochondrial-dependent apoptosis through inhibition of PKA/NF-kappaB in renal proximal epithelial cells.
Toxicology.
2009 Apr; 258(1):17-24. doi:
10.1016/j.tox.2009.01.001
. [PMID: 19167456] - Takeshi Tsuji, Masato Asanuma, Ikuko Miyazaki, Ko Miyoshi, Norio Ogawa. Reduction of nuclear peroxisome proliferator-activated receptor gamma expression in methamphetamine-induced neurotoxicity and neuroprotective effects of ibuprofen.
Neurochemical research.
2009 Apr; 34(4):764-74. doi:
10.1007/s11064-008-9863-x
. [PMID: 18946735] - Tsuyoshi Waku, Takuma Shiraki, Takuji Oyama, Yoshito Fujimoto, Kanako Maebara, Narutoshi Kamiya, Hisato Jingami, Kosuke Morikawa. Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids.
Journal of molecular biology.
2009 Jan; 385(1):188-99. doi:
10.1016/j.jmb.2008.10.039
. [PMID: 18977231] - Jee Hoon Lee, Joo Hong Woo, Sang Uk Woo, Kwang Soo Kim, Sang Myun Park, Eun-hye Joe, Ilo Jou. The 15-deoxy-delta 12,14-prostaglandin J2 suppresses monocyte chemoattractant protein-1 expression in IFN-gamma-stimulated astrocytes through induction of MAPK phosphatase-1.
Journal of immunology (Baltimore, Md. : 1950).
2008 Dec; 181(12):8642-9. doi:
10.4049/jimmunol.181.12.8642
. [PMID: 19050284] - Eun-Hee Kim, Young-Joon Surh. The role of 15-deoxy-delta(12,14)-prostaglandin J(2), an endogenous ligand of peroxisome proliferator-activated receptor gamma, in tumor angiogenesis.
Biochemical pharmacology.
2008 Dec; 76(11):1544-53. doi:
10.1016/j.bcp.2008.07.043
. [PMID: 18771658] - Ulf Panzer, Gunther Zahner, Ulrike Wienberg, Oliver M Steinmetz, Anett Peters, Jan-Eric Turner, Hans-Joachim Paust, Gunter Wolf, Rolf A K Stahl, André Schneider. 15-deoxy-Delta12,14-prostaglandin J2 inhibits INF-gamma-induced JAK/STAT1 signalling pathway activation and IP-10/CXCL10 expression in mesangial cells.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2008 Dec; 23(12):3776-85. doi:
10.1093/ndt/gfn361
. [PMID: 18596134] - Hideki Kimura, Xuan Li, Kunio Torii, Toshiharu Okada, Naoki Takahashi, Hiroshi Fujii, Shunji Ishihara, Haruyoshi Yoshida. A natural PPAR-gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, may act as an enhancer of PAI-1 in human proximal renal tubular cells under hypoxic and inflammatory conditions.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2008 Aug; 23(8):2496-503. doi:
10.1093/ndt/gfn139
. [PMID: 18367541] - Evangelina Capobianco, Verónica White, Romina Higa, Nora Martínez, Alicia Jawerbaum. Effects of natural ligands of PPARgamma on lipid metabolism in placental tissues from healthy and diabetic rats.
Molecular human reproduction.
2008 Aug; 14(8):491-9. doi:
10.1093/molehr/gan039
. [PMID: 18621767] - Lillian Cruz-Orengo, Ajay Dhaka, Robert J Heuermann, Timothy J Young, Michael C Montana, Eric J Cavanaugh, Donghee Kim, Gina M Story. Cutaneous nociception evoked by 15-delta PGJ2 via activation of ion channel TRPA1.
Molecular pain.
2008 Jul; 4(?):30. doi:
10.1186/1744-8069-4-30
. [PMID: 18671867] - Simon J Crabb, Angela Hague, Peter W M Johnson, Graham Packham. BAG-1 inhibits PPARgamma-induced cell death, but not PPARgamma-induced transcription, cell cycle arrest or differentiation in breast cancer cells.
Oncology reports.
2008 Mar; 19(3):689-96. doi:
10.3892/or.19.3.689
. [PMID: 18288403] - Basilia Zingarelli, Paul W Hake, Prajakta Mangeshkar, Michael O'Connor, Timothy J Burroughs, Giovanna Piraino, Alvin Denenberg, Hector R Wong. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
Shock (Augusta, Ga.).
2007 Nov; 28(5):554-63. doi:
10.1097/shk.0b013e31804f56b9
. [PMID: 17589386] - Gemma Olmos, Isabel Conde, Isabel Arenas, Luis Del Peso, Carmen Castellanos, Manuel O Landazuri, Javier Lucio-Cazana. Accumulation of hypoxia-inducible factor-1alpha through a novel electrophilic, thiol antioxidant-sensitive mechanism.
Cellular signalling.
2007 Oct; 19(10):2098-105. doi:
10.1016/j.cellsig.2007.06.004
. [PMID: 17658243] - Enrico M Brunoldi, Giuseppe Zanoni, Giovanni Vidari, Soumya Sasi, Michael L Freeman, Ginger L Milne, Jason D Morrow. Cyclopentenone prostaglandin, 15-deoxy-Delta12,14-PGJ2, is metabolized by HepG2 cells via conjugation with glutathione.
Chemical research in toxicology.
2007 Oct; 20(10):1528-35. doi:
10.1021/tx700231a
. [PMID: 17854155] - Yoshiro Saito, Keiko Nishio, Yumiko Numakawa, Yoko Ogawa, Yasukazu Yoshida, Noriko Noguchi, Etsuo Niki. Protective effects of 15-deoxy-Delta12,14-prostaglandin J2 against glutamate-induced cell death in primary cortical neuron cultures: induction of adaptive response and enhancement of cell tolerance primarily through up-regulation of cellular glutathione.
Journal of neurochemistry.
2007 Sep; 102(5):1625-1634. doi:
10.1111/j.1471-4159.2007.04701.x
. [PMID: 17697048] - Yumei Ye, Shawn P Nishi, Saraswathy Manickavasagam, Yu Lin, Ming-He Huang, J Regino Perez-Polo, Barry F Uretsky, Yochai Birnbaum. Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2.
Prostaglandins & other lipid mediators.
2007 Aug; 84(1-2):43-53. doi:
10.1016/j.prostaglandins.2007.04.001
. [PMID: 17643887] - Yen-Chuan Ou, Chi-Rei Yang, Chen-Li Cheng, Shue-Ling Raung, Yu-Yeh Hung, Chun-Jung Chen. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
European journal of pharmacology.
2007 Jun; 563(1-3):49-60. doi:
10.1016/j.ejphar.2007.01.071
. [PMID: 17341418] - Yuji Tanaka, Jonathan M Maher, Chuan Chen, Curtis D Klaassen. Hepatic ischemia-reperfusion induces renal heme oxygenase-1 via NF-E2-related factor 2 in rats and mice.
Molecular pharmacology.
2007 Mar; 71(3):817-25. doi:
10.1124/mol.106.029033
. [PMID: 17151289] - Francisco J Sánchez-Gómez, Javier Gayarre, M Isabel Avellano, Dolores Pérez-Sala. Direct evidence for the covalent modification of glutathione-S-transferase P1-1 by electrophilic prostaglandins: implications for enzyme inactivation and cell survival.
Archives of biochemistry and biophysics.
2007 Jan; 457(2):150-9. doi:
10.1016/j.abb.2006.10.032
. [PMID: 17169324] - Shigeharu Ueki, Hikari Kato, Yoshiki Kobayashi, Wataru Ito, Tetsuya Adachi, Hiroyuki Nagase, Ken Ohta, Hiroyuki Kayaba, Junichi Chihara. Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions.
International archives of allergy and immunology.
2007; 143 Suppl 1(?):15-22. doi:
10.1159/000101399
. [PMID: 17541271] - Dae Sik Kang, Chae Hwa Kwon, Ji Yeon Park, Jae Ho Kim, Jae Suk Woo, Jin Sup Jung, Yong Keun Kim. 15-deoxy-Delta12,14-prostaglandin J2 induces renal epithelial cell death through NF-kappaB-dependent and MAPK-independent mechanism.
Toxicology and applied pharmacology.
2006 Nov; 216(3):426-35. doi:
10.1016/j.taap.2006.06.008
. [PMID: 16890972] - Xiang Yu, Patricia A Egner, Junko Wakabayashi, Nobunao Wakabayashi, Masayuki Yamamoto, Thomas W Kensler. Nrf2-mediated induction of cytoprotective enzymes by 15-deoxy-Delta12,14-prostaglandin J2 is attenuated by alkenal/one oxidoreductase.
The Journal of biological chemistry.
2006 Sep; 281(36):26245-52. doi:
10.1074/jbc.m604620200
. [PMID: 16857669] - François Willermain, Simon Dulku, Nathalie Suarez Gonzalez, Daniel Blero, Gregory Driessens, Chantal De Graef, Laure Caspers, Catherine Bruyns. 15-Deoxy-12,14-prostaglandin J2 inhibits interferon gamma induced MHC class II but not class I expression on ARPE cells through a PPAR gamma independent mechanism.
Prostaglandins & other lipid mediators.
2006 Sep; 80(3-4):136-43. doi:
10.1016/j.prostaglandins.2006.06.001
. [PMID: 16939878] - Chi-Hsiao Yeh, Tzu-Ping Chen, Chieh-Hung Lee, Yi-Chen Wu, Yu-Min Lin, Pyng Jing Lin. Cardiomyocytic apoptosis following global cardiac ischemia and reperfusion can be attenuated by peroxisome proliferator-activated receptor alpha but not gamma activators.
Shock (Augusta, Ga.).
2006 Sep; 26(3):262-70. doi:
10.1097/01.shk.0000225863.56714.96
. [PMID: 16912651] - Sik Lee, Won Kim, Sang-Ok Moon, Mi Jeong Sung, Duk Hoon Kim, Kyung Pyo Kang, Yong Bum Jang, Jung Eun Lee, Kyu Yun Jang, Sung Kwang Park. Rosiglitazone ameliorates cisplatin-induced renal injury in mice.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2006 Aug; 21(8):2096-105. doi:
10.1093/ndt/gfl194
. [PMID: 16728429] - Zhi-Hua Chen, Yasukazu Yoshida, Yoshiro Saito, Azusa Sekine, Noriko Noguchi, Etsuo Niki. Induction of adaptive response and enhancement of PC12 cell tolerance by 7-hydroxycholesterol and 15-deoxy-delta(12,14)-prostaglandin J2 through up-regulation of cellular glutathione via different mechanisms.
The Journal of biological chemistry.
2006 May; 281(20):14440-5. doi:
10.1074/jbc.m600260200
. [PMID: 16565077] - Oliver Schröder, Yulyana Yudina, Alan Sabirsh, Nadine Zahn, Jesper Z Haeggström, Jürgen Stein. 15-deoxy-Delta12,14-prostaglandin J2 inhibits the expression of microsomal prostaglandin E synthase type 2 in colon cancer cells.
Journal of lipid research.
2006 May; 47(5):1071-80. doi:
10.1194/jlr.m600008-jlr200
. [PMID: 16495511] - Balázs Hauser, Jochen Kick, Zsolt Iványi, Pierre Asfar, Ulrich Ehrmann, Claus-Martin Muth, Maura Albicini, Ulrich Wachter, Josef Vogt, Michael Bauer, Uwe Bernd Brückner, Peter Radermacher, Hendrik Bracht. Effects of 15-deoxy-Delta12,14-prostaglandin-J2 during hyperdynamic porcine endotoxemia.
Intensive care medicine.
2006 May; 32(5):759-65. doi:
10.1007/s00134-006-0107-8
. [PMID: 16534570] - Etsuko Yasugi, Akiko Horiuchi, Isao Uemura, Emiko Okuma, Masami Nakatsu, Kumiko Saeki, Yasushi Kamisaka, Hiroyuki Kagechika, Kazuki Yasuda, Akira Yuo. Peroxisome proliferator-activated receptor gamma ligands stimulate myeloid differentiation and lipogenensis in human leukemia NB4 cells.
Development, growth & differentiation.
2006 Apr; 48(3):177-88. doi:
10.1111/j.1440-169x.2006.00855.x
. [PMID: 16573735] - Aimee Landar, Sruti Shiva, Anna-Liisa Levonen, Joo-Yeun Oh, Corinne Zaragoza, Michelle S Johnson, Victor M Darley-Usmar. Induction of the permeability transition and cytochrome c release by 15-deoxy-Delta12,14-prostaglandin J2 in mitochondria.
The Biochemical journal.
2006 Feb; 394(Pt 1):185-95. doi:
10.1042/bj20051259
. [PMID: 16268779] - Being-Sun Wung, Ming-Chun Hsu, Chun-Ching Wu, Chia-Wen Hsieh. Piceatannol upregulates endothelial heme oxygenase-1 expression via novel protein kinase C and tyrosine kinase pathways.
Pharmacological research.
2006 Feb; 53(2):113-22. doi:
10.1016/j.phrs.2005.09.006
. [PMID: 16243536] - Hitoshi Masuda, Michael B Chancellor, Kazunori Kihara, Naoki Yoshimura. 15-deoxy-Delta12,14-prostaglandin J2 attenuates development of cyclophosphamide-induced cystitis in rats.
Urology.
2006 Feb; 67(2):435-9. doi:
10.1016/j.urology.2005.08.052
. [PMID: 16461118] - Shizuka Kohno, Hirahito Endo, Atsushi Hashimoto, Izumi Hayashi, Yusuke Murakami, Hidero Kitasato, Fumiaki Kojima, Shinichi Kawai, Hirobumi Kondo. Inhibition of skin sclerosis by 15deoxy delta12,14-prostaglandin J2 and retrovirally transfected prostaglandin D synthase in a mouse model of bleomycin-induced scleroderma.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
2006 Jan; 60(1):18-25. doi:
10.1016/j.biopha.2005.04.004
. [PMID: 16337105] - Seong-Ho Koh, Boo Jung, Chi Won Song, Youngchul Kim, Yong Soon Kim, Seung Hyun Kim. 15-Deoxy-delta12,14-prostaglandin J2, a neuroprotectant or a neurotoxicant?.
Toxicology.
2005 Dec; 216(2-3):232-43. doi:
10.1016/j.tox.2005.08.015
. [PMID: 16191461] - Tadaatsu Imaizumi, Koji Yamashita, Kageaki Taima, Akira Ishikawa, Hidemi Yoshida, Kei Satoh. Effect of peroxisome proliferator-activated receptor-gamma ligands on the expression of retinoic acid-inducible gene-I in endothelial cells stimulated with lipopolysaccharide.
Prostaglandins & other lipid mediators.
2005 Dec; 78(1-4):46-54. doi:
10.1016/j.prostaglandins.2005.02.006
. [PMID: 16303604] - Chikakazu Iwata, Noriko Akimoto, Takashi Sato, Yuki Morokuma, Akira Ito. Augmentation of lipogenesis by 15-deoxy-Delta12,14-prostaglandin J2 in hamster sebaceous glands: identification of cytochrome P-450-mediated 15-deoxy-Delta12,14-prostaglandin J2 production.
The Journal of investigative dermatology.
2005 Nov; 125(5):865-72. doi:
10.1111/j.0022-202x.2005.23866.x
. [PMID: 16297182] - Yoshiki Kobayashi, Shigeharu Ueki, Gulixian Mahemuti, Takahito Chiba, Hajime Oyamada, Norihiro Saito, Akira Kanda, Hiroyuki Kayaba, Junichi Chihara. Physiological levels of 15-deoxy-Delta12,14-prostaglandin J2 prime eotaxin-induced chemotaxis on human eosinophils through peroxisome proliferator-activated receptor-gamma ligation.
Journal of immunology (Baltimore, Md. : 1950).
2005 Nov; 175(9):5744-50. doi:
10.4049/jimmunol.175.9.5744
. [PMID: 16237065] - Hyo Jin Kim, Young Hee Rho, Seong Jai Choi, Young Ho Lee, HyeonJoo Cheon, Jun Won Um, Jeongwon Sohn, Gwan Gyu Song, Jong Dae Ji. 15-Deoxy-delta12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes.
Experimental & molecular medicine.
2005 Jun; 37(3):179-85. doi:
10.1038/emm.2005.24
. [PMID: 16000871] - Yuka Unno, Masakazu Sakai, Yu-Ichiro Sakamoto, Akihiko Kuniyasu, Ryoji Nagai, Hitoshi Nakayama, Seikoh Horiuchi. Glycolaldehyde-modified bovine serum albumin downregulates leptin expression in mouse adipocytes via a CD36-mediated pathway.
Annals of the New York Academy of Sciences.
2005 Jun; 1043(?):696-701. doi:
10.1196/annals.1333.080
. [PMID: 16037295] - Stefania Marzocco, Rosanna Di Paola, Emanuela Mazzon, Tiziana Genovese, Domenico Britti, Aldo Pinto, Giuseppina Autore, Salvatore Cuzzocrea. The cyclopentenone prostaglandin 15-deoxydelta(12,14)-prostaglandin J2 attenuates the development of zymosan-induced shock.
Intensive care medicine.
2005 May; 31(5):693-700. doi:
10.1007/s00134-005-2596-2
. [PMID: 15868139] - A C Maurin, P M Chavassieux, P J Meunier. Expression of PPARgamma and beta/delta in human primary osteoblastic cells: influence of polyunsaturated fatty acids.
Calcified tissue international.
2005 May; 76(5):385-92. doi:
10.1007/s00223-004-0108-y
. [PMID: 15868283] - Takuma Shiraki, Narutoshi Kamiya, Sayaka Shiki, Takashi S Kodama, Akira Kakizuka, Hisato Jingami. Alpha,beta-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor gamma.
The Journal of biological chemistry.
2005 Apr; 280(14):14145-53. doi:
10.1074/jbc.m500901200
. [PMID: 15695504] - Tokuji Tanaka, Yasutomo Fukunaga, Hiroshi Itoh, Kentaro Doi, Jun Yamashita, Tae-Hwa Chun, Mayumi Inoue, Ken Masatsugu, Takatoshi Saito, Naoki Sawada, Satsuki Sakaguchi, Hiroshi Arai, Kazuwa Nakao. Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration.
European journal of pharmacology.
2005 Jan; 508(1-3):255-65. doi:
10.1016/j.ejphar.2004.10.056
. [PMID: 15680279] - E Capobianco, A Jawerbaum, M C Romanini, V White, C Pustovrh, R Higa, N Martinez, M T Mugnaini, C Soñez, E Gonzalez. 15-Deoxy-Delta12,14-prostaglandin J2 and peroxisome proliferator-activated receptor gamma (PPARgamma) levels in term placental tissues from control and diabetic rats: modulatory effects of a PPARgamma agonist on nitridergic and lipid placental metabolism.
Reproduction, fertility, and development.
2005; 17(4):423-33. doi:
10.1071/rd04067
. [PMID: 15899154] - M-G Zurich, S Lengacher, O Braissant, F Monnet-Tschudi, L Pellerin, P Honegger. Unusual astrocyte reactivity caused by the food mycotoxin ochratoxin A in aggregating rat brain cell cultures.
Neuroscience.
2005; 134(3):771-82. doi:
10.1016/j.neuroscience.2005.04.030
. [PMID: 15994020] - Alicja Józkowicz, Anneliese Nigisch, Birgitta Winter, Guenter Weigel, Ihor Hukb, Józef Dulaka. 15-deoxy-delta12,14-prostaglandin-J2 inhibits expression of eNOS in human endothelial cells.
Prostaglandins & other lipid mediators.
2004 Oct; 74(1-4):11-28. doi:
10.1016/j.prostaglandins.2004.05.001
. [PMID: 15560113] - M M T Downie, D A Sanders, L M Maier, D M Stock, T Kealey. Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro.
The British journal of dermatology.
2004 Oct; 151(4):766-75. doi:
10.1111/j.1365-2133.2004.06171.x
. [PMID: 15491415] - Marika Collin, Nimesh S A Patel, Laura Dugo, Christoph Thiemermann. Role of peroxisome proliferator-activated receptor-gamma in the protection afforded by 15-deoxydelta12,14 prostaglandin J2 against the multiple organ failure caused by endotoxin.
Critical care medicine.
2004 Mar; 32(3):826-31. doi:
10.1097/01.ccm.0000114821.25573.e7
. [PMID: 15090969] - Anna-Liisa Levonen, Aimee Landar, Anup Ramachandran, Erin K Ceaser, Dale A Dickinson, Giuseppe Zanoni, Jason D Morrow, Victor M Darley-Usmar. Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products.
The Biochemical journal.
2004 Mar; 378(Pt 2):373-82. doi:
10.1042/bj20031049
. [PMID: 14616092] - Alan P Kumar, F Javier Piedrafita, Wanda F Reynolds. Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism.
The Journal of biological chemistry.
2004 Feb; 279(9):8300-15. doi:
10.1074/jbc.m311625200
. [PMID: 14668325] - Prabal Kumar Chatterjee, Nimesh S A Patel, Salvatore Cuzzocrea, Paul A J Brown, Keith N Stewart, Helder Mota-Filipe, Domenico Britti, Wolfgang Eberhardt, Josef Pfeilschifter, Christoph Thiemermann. The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J2 ameliorates ischemic acute renal failure.
Cardiovascular research.
2004 Feb; 61(3):630-43. doi:
10.1016/j.cardiores.2003.10.024
. [PMID: 14962493] - Basilia Zingarelli, Maeve Sheehan, Paul W Hake, Michael O'Connor, Alvin Denenberg, James A Cook. Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways.
Journal of immunology (Baltimore, Md. : 1950).
2003 Dec; 171(12):6827-37. doi:
10.4049/jimmunol.171.12.6827
. [PMID: 14662889] - Li Yang, Dong Yan, Cong Yan, Hong Du. Peroxisome proliferator-activated receptor gamma and ligands inhibit surfactant protein B gene expression in the lung.
The Journal of biological chemistry.
2003 Sep; 278(38):36841-7. doi:
10.1074/jbc.m304156200
. [PMID: 12829715] - Salvatore Cuzzocrea, Barbara Pisano, Laura Dugo, Angela Ianaro, Nimesh S A Patel, Rosanna Di Paola, Tiziana Genovese, Prabal K Chatterjee, Massimo Di Rosa, Achille P Caputi, Christoph Thiemermann. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
British journal of pharmacology.
2003 Sep; 140(2):366-76. doi:
10.1038/sj.bjp.0705419
. [PMID: 12970094] - L Chastine Bell-Parikh, Tomomi Ide, John A Lawson, Peter McNamara, Muredach Reilly, Garret A FitzGerald. Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma.
The Journal of clinical investigation.
2003 Sep; 112(6):945-55. doi:
10.1172/jci18012
. [PMID: 12975479]